ISRCTN38025852已完成不适用
epafenac and prevention of cystoid macular edema (CME) after cataract surgery in patients receiving latanoprost: a randomised controlled trial
Chulalongkorn University (Thailand)0 个研究点目标入组 80 人开始时间: 2010年12月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Eyes receiving 0.005% Latanoprost at least 1-month prior to a planned phacoemulsification with PC-IOL implantation
- •2. Aged over 18 years, either sex
排除标准
- •1. History of intra-ocular inflammation
- •2. Clinically significant macular edema (CSME), or macular oedema of any aetiology
- •3. Proliferative diabetic retinopathy
- •4. Retinitis pigmentosa
- •5. Prior vitreo-retinal surgery
- •6. Pregnancy
- •7. Known/suspicious allergy to non-steroidal anti-inflammatory drugs (NSAIDs)/prostaglandin analogues
- •8. Physical/mental/intellectual disabilities preventing from understanding and complying to protocol
研究者
相似试验
已完成
不适用
Prevention of post-cataract surgery macula oedema with prophylactic ketorolacCystoid macular oedema (CMO)Eye DiseasesOther retinal disordersISRCTN02628492Frimley Park Hospital NHS Foundation Trust (UK)1,400
进行中（未招募）
不适用
Prevention of pseudophakic cystoid macula oedema with pre- and postoperative ketorolac - Prevention of CMO with pre and postop ketorolaccystoid macula oedemaEUCTR2008-001843-20-GBFrimley Park Hospital1,390
已完成
不适用
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus PlaceboCystoid Macular EdemaNCT03025945Intuor Technologies, Inc.662
招募中
3 期
epafenac and Prevention of CME after Cataract Surgery in Patients Receiving Latanoprost: A Randomized Controlled TrialCMECystoid macular oedemaProstaglandinLatanoprostNepafenacNSAIDsCataract surgeryPhacoemulsificationOCTOptical coherence tomographyTCTR20110000013Glaucoma Research Fund80
招募中
4 期
Therapy of recalcitrant macular edema in aphakic and/or eyes with with severe iris-lens diaphragm disruption with longterm intravitreal steroid implants such as Iluvien® or Ozurdex®.recalcitrant macular edemaH35.8Other specified retinal disordersDRKS00020282Augenklinik des Klnikums der Ludwig-Maximilians-Universität München40